NCT02496039View on ClinicalTrials.gov

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

PHASE4TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Pseudobulbar Affect (Involuntary Laughing and/or Crying)
Interventions
DRUG

NUEDEXTA®

NUEDEXTA® only

Trial Locations (2)

33137

Miami

45459

Centerville

Sponsors
All Listed Sponsors
lead

Avanir Pharmaceuticals

INDUSTRY